Trials / Completed
CompletedNCT02407197
International T1 Multicentre CMR Outcome Study
International T1 Multicentre CMR Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,629 (actual)
- Sponsor
- King's College London · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Myocardial fibrosis is the fundamental substrate for the development of heart failure. Cardiovascular magnetic resonance (CMR) allows non-invasive assessment of myocardial fibrosis based on late gadolinium enhancement (LGE) and T1 mapping. Patients: Prospective longitudinal observational multicenter study of consecutive patients with suspected or known non-ischemic cardiomyopathy. Imaging: Non-invasive measures of myocardial fibrosis: native T1, extracellular volume fraction (ECV) and LGE. Primary endpoints: all cause and cardiovascular mortality. Secondary endpoints: arrhythmic composite and HF composite endpoints.
Conditions
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2017-12-01
- Completion
- 2022-12-01
- First posted
- 2015-04-02
- Last updated
- 2023-03-09
Locations
4 sites across 3 countries: Australia, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT02407197. Inclusion in this directory is not an endorsement.